Crossmark

Anti-PD-1-based immunotherapy plus lenvatinib to treat advanced gallbladder cancer in the elderly: a case series and review of current literature

Published Online: 2022-06-27

Published Print: 2023-03

Authors

Wang, Lantian

Tang, Kezhong

Li, Xiawei

Lu, Wenjie
License Information

Text and Data Mining valid from 2022-06-27

Version of Record valid from 2022-06-27
More Information

Article History

Received: 4 May 2022

Accepted: 8 June 2022

First Online: 27 June 2022

Declarations

:

: The authors declare that they have no competing interests.

Document is current